Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × gemcitabine-oxaliplatin regimen × Clear all

NCT00169195 2015-09-02

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

Phase 2 Completed

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse